Cardio Diagnostics-CW26CDIOWPreferred / convertible
13F holders, Q4 2024 (December 31)6holders −4
0new positions
4sold out
1famous investor
$0.17avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Cardio Diagnostics-CW26 (CDIOW) in their 13F filings, down 4 from Q3 2024. 0 opened new positions and 4 sold out. The largest holders were Boothbay Fund Management, LLC ($56K), Saba Capital Management, L.P. ($17K) and Clear Street LLC ($7K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Cardio Diagnostics-CW26
- CUSIP
- 14159C111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 4 | $15K |
All 13F filers, Q3 2024 → Q4 2024: 388,740 shares sold, net −388,740 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Boothbay Fund Management, LLC | — | No change | 60,540 | $56K |
| Saba Capital Management, L.P. | — | No change | 199,839 | $17K |
| Clear Street LLC | — | Reduce -0.2% | 82,842 | $7K |
| Context Capital Management, LLC | — | No change | 81,500 | $7K |
| D. E. Shaw & Co. | — | No change | 74,822 | $6K |
| Atw Spac Management LLC | — | No change | 60,540 | $5K |
"% of holder's portfolio" is CDIOW's weight in each manager's 13F, not the share of Cardio Diagnostics-CW26 the manager owns.